S.V. Kane, S. Horst, W.J. Sandborn, B. Becker, B. Neis, M. Moscandrew, K.A. Hanson, W.J. Tremaine, D.H. Bruining, W.A. Faubion, D.S. Pardi, W.S. Harmsen, A.R. Zinsmeister and E.V. Loftus Natalizumab for moderate to severe Crohn's disease in clinical practice: The Mayo Clinic Rochester experience Inflammatory Bowel Diseases 18
Article first published online: 14 MAR 2012 | DOI: 10.1002/ibd.22943
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Copyright © 1999–2013 John Wiley & Sons, Inc. All Rights Reserved.